Zinc and nicotinic acetylcholine receptors (nAChRs) seem to be associated with major depression, and some antidepressants, including fluoxetine (Prozac), antagonize nAChRs. Therefore, a study was made of the modulation of neuronal a4b4 and muscle a1b1gd nAChRs, expressing in oocytes, by the combined action of zinc and fluoxetine. At a holding potential of -60 mV, 200 mM zinc increased by 361% the currents elicited by acetylcholine (ACh currents) for a4b4 and by 182% for a1b1gd nAChRs. In contrast, 5 mM fluoxetine reduced the ACh currents to 31% for a4b4 and to 45% for a1b1gd nAChRs. Additionally, fluoxetine reduced more the ACh currents in the presence of zinc: to 17% for a4b4 and to 19% for a1b1gd nAChRs, and after washing out the fluoxetine the ACh current did not recover its zinc-potentiated value. Moreover, when ACh-activated nAChRs were exposed first to fluoxetine and then zinc was added, the potentiating effect of zinc was very small for muscle nAChRs and was nil for neuronal receptors. Thus, the inhibiting effect of fluoxetine prevails over the potentiating action of zinc. Finally, the effects of both zinc and fluoxetine were voltage independent, indicating that these substances interact outside the ion channel. As fluoxetine nullifies the effects of zinc, it appears that both substances interact in the same site. These results should help understand better the roles played by zinc, antidepressants, nAChRs and their combination in brain functions and in the treatment of depression.
INTRODUCTION
Nicotinic acetylcholine receptors (nAChRs) are involved in many complex brain functions such as memory, attention and cognition, as well as in some neuropsychiatric disorders such as Alzheimer's and Parkinson diseases, schizophrenia, anxiety and depression. 1, 2 Fast synaptic cholinergic transmission at the neuromuscular junction and at peripheral nervous system synapses is mediated by postsynaptic nAChRs. In contrast, central nAChRs are predominantly presynaptic and modulate the release of various neurotransmitters: for example, 5-hydroxytryptamine (5-HT, serotonin), glutamate, g-aminobutyric acid (GABA), norepinephrine, acetylcholine (ACh) and dopamine. 3 The nAChRs are relatively nonselective cation channels opened by ACh, and belong to the same gene superfamily that includes GABA A , GABA C , glycine and 5-HT 3 receptors. 4 Many endogenous and exogenous substances modify the function of nAChRs. For instance, they are modulated by cations, [5] [6] [7] [8] 5-HT, 9-13 various agonists and antagonists of different types of 5-HT receptors, [9] [10] [11] [12] 14 as well as inhibitors of monoamine transporters that are used as antidepressants. 9, 12, [15] [16] [17] [18] [19] [20] The most common action of clinically used antidepressants on nAChRs appears to be a noncompetitive inhibitory process, 9, 12, [15] [16] [17] [18] [19] [20] and it is probable that this action contributes to improving depressed mood states. 21 On the other hand, zinc is contained in neurons that are widely distributed throughout the nervous system; 22 and it is released from GABAergic and glutamatergic nerve endings, 23, 24 reaching an extracellular concentration of B300 mM. 25 This cation modulates synaptic transmission by interacting with pre-and postsynaptic membrane proteins, such as receptors and ion channels. 26 To date, relatively few studies have been concerned with the effects of zinc on nAChRs. For example, zinc is known to modulate nAChRs in a biphasic manner: potentiating and inhibiting the ACh response, depending on the subunit composition of the receptors, 7 probably by interacting at two different sites on the nAChR.
On the other hand, it is important to note that zinc has been linked to the psychopathology and treatment of depression. 27, 28 Additionally, zinc content is not altered in the hippocampus, and the potency of zinc to inhibit Nmethyl-D-aspartate receptors is reduced in suicidal victims. 29 Thus, zinc appears to exert antidepressant-like effects probably by interacting with N-methyl-D-aspartate receptors and involving the L-arginine-nitric oxide pathway. 30, 31 It is clear: (a) that both zinc and antidepressants interact with nAChRs, (b) that these two substances are intimately related with depression and its treatment and (c) that nAChRs are involved in such disorders as anxiety and mental depression. Furthermore, zinc enhances the effect of antidepressants in animal models of depression 32 and zinc supplementation seems to increase the efficacy of antidepressant therapy in patients with unipolar depression. 33 In the present study, we examine the effects of exposing nAChRs to the simultaneous action of zinc and fluoxetine.
RESULTS

Effects of Zinc and Fluoxetine on Neuronal nAChRs
To reduce desensitization, the membrane currents were induced by relatively low concentrations of ACh applied to oocytes expressing neuronal a4b4 or muscle a1b1gd nAChRs. When 200 mM zinc or 5 mM fluoxetine were applied alone to noninjected or to injected oocytes, no measurable membrane currents were observed.
It is known that zinc potentiates the ACh current, 6, 7 and that fluoxetine has a clear blocking effect on the ACh currents mediated by either muscle or neuronal nAChRs. 12, 16 Figure 1 illustrates an example of these effects on oocytes expressing neuronal a4b4 nAChRs. An inward current was elicited with ACh, and after the peak had been reached 200 mM zinc was co-applied with the ACh (Figure  1a, a) . This caused the ACh current to increase to 361713% Figure 1 ACh currents during co-application of zinc and fluoxetine on neuronal nAChRs. After reaching the peak ACh current, zinc was added following fluoxetine (a), or fluoxetine was first added following zinc (b). The letters (a-e) are to highlight the effect of each substance. For this and subsequent figures, the oocyte membrane potential was maintained at À60 mV and ACh, zinc and fluoxetine were applied during the times indicated by the continuous, dashed and dotted lines, respectively. Substance changes were marked by voltage steps, which also monitor membrane conductance changes. Records were from different oocytes.
(n ¼ 5). In contrast, when 5 mM fluoxetine was added ( Figure  1b , a), the ACh current was decreased to 30.774.5% (n ¼ 4). The ACh current potentiation by zinc was associated with an increase in membrane conductance, whereas the ACh current inhibition by fluoxetine was associated with a decrease in membrane conductance. Both the onset of the effects and their recovery were slower for fluoxetine than for zinc (cf. Figure 1a , b).
Combined Actions of Zinc and Fluoxetine on Neuronal nAChRs
In animal models of depression, and in patients with major depression, zinc favors the effects of antidepressants. 32, 33 Therefore, we decided to examine further the effects of zinc and fluoxetine on nAChRs. For these experiments, after eliciting the ACh current in oocytes expressing nAChRs, the two substances were applied together and in different sequence. For example, after the ACh current had been potentiated by zinc, fluoxetine was added (Figure 1a, b) , still in the presence of zinc. This caused the ACh current to decrease to 1771.8% (n ¼ 3), that is, less than the nonpotentiated level. Interestingly, after co-application of fluoxetine ceased, the current recovered only slightly (Figure 1a, c-d) .
A different sequence is illustrated in Figure 1b , where the ACh current was first inhibited by fluoxetine (Figure 1b, a) , and then zinc was added (Figure 1b, b) . Surprisingly, now zinc failed to cause the ACh current to increase, and after the three substances had been transiently co-applied the ACh current recovery was very slow.
Co-application of Zinc and Fluoxetine to Muscle nAChRs
If similar drug applications were performed in oocytes expressing muscle a1b1gd nAChRs, the results were slightly different. The effects of simultaneous applications of the three substances were less marked and the recovery, after stopping the third (fluoxetine or zinc, Figure 2 ), was greater than that seen for the neuronal receptors. Thus, zinc increased the ACh current to 182722%, n ¼ 6 (Figure 2a, b) and fluoxetine decreased it to 4574%, n ¼ 4 (Figure 2b, b) .
Note that inhibition of the ACh current by fluoxetine was still progressing after 2 min (Figure 2a, b-c, b, a-b) . Therefore, the application of fluoxetine was prolonged and this led to a stronger inhibition of the ACh current. Furthermore, the inhibition of the ACh current by fluoxetine was stronger in the presence of zinc, which reached to 1972% (n ¼ 3) of the zinc-potentiated ACh current (Figure 2c, c) , than in its absence, to 3072% (n ¼ 3) of the ACh current (Figure 2d, b) . Additionally, zinc increased slightly the ACh current in the presence of fluoxetine on muscle a1b1gd nAChRs (Figure 2b, c, d, c) , while the ACh current elicited by neuronal receptors was not altered (Figure 1b, c) . These results show that fluoxetine acts stronger on neuronal than on muscle nAChRs, and that the inhibitory effects of fluoxetine are reversed by zinc at muscle nAChRs.
These effects of fluoxetine were also produced by the combined action of 200 mM zinc with 5 mM imipramine or trimipramine on neuronal a3b4 and a4b4 receptors, as well as on muscle a1b1gd nAChRs (data not shown), indicating that these effects are characteristic of some antidepressant drugs.
Voltage Effects of Zinc and Fluoxetine on Neuronal nAChRs
To gain some insight on their sites of action, we examined the effects of zinc and fluoxetine on the ACh current, on oocytes expressing neuronal a4b4 nAChRs, as a function of voltage, by holding the oocyte at -60 mV and giving 2 s voltage ramps (À120 to 40 mV) at various times during the drug applications (eg Figure 3) .
The ACh current to voltage (I-V) relationships for the different drug sequences were obtained by subtracting the response induced by the voltage-ramp in normal Ringer solution from the response induced by voltage-ramp in the other solutions. The I-V relation in the presence of ACh plus zinc (Figure 3b ) was slightly voltage-dependent and increased B3-fold at all voltages (Figure 3b, ratio) . On the other hand, the fluoxetine block of the zinc-potentiated ACh current was strong (Figure 3c ) and the I-V relation was voltage-independent (Figure 3c , ratio), indicating that zinc and fluoxetine in the presence of zinc interact in an external region of the receptor-channel complex. All the I-V relations showed that the equilibrium potential remained unaltered (ca. 12 mV), and all displayed the inward rectification characteristic of ACh current mediated by neuronal nAChRs, 10, 18 such that at voltages more positive than zero the membrane current was near zero.
DISCUSSION
The central findings of this study are that, at relatively low concentrations, zinc potentiates and fluoxetine inhibits the action of ACh on both neuronal and muscle nAChRs, and that the presence of fluoxetine greatly reduces, or abolishes, the potentiating action of zinc. These actions may be important towards determining the etiology and treatment of mental depression, because zinc and fluoxetine, 28, 34 as well as the nicotinic receptor system, 2, 35 have been implicated in the disease.
The extracellular concentration of zinc (B300 mM) that is reached in the central nervous system, during co-release with glutamate, 25 is sufficient to positively modulate presynaptic nAChRs, which may be located in the same terminals from which zinc is released. 36 Moreover, the plasma concentration of fluoxetine during effective clinical treatment (B1 mM) 37 and the concentration in the brain relative to that in the plasma (20 : 1) 38 make it very likely that during the treatment of mental depression fluoxetine is exerting a marked inhibiting action on nAChRs. The inhibition of nAChRs would be increased further by 5-HT, 9,10 whose concentration is raised by the inhibitory action of fluoxetine on the 5-HT transporter. 34 On the other hand, it is known that the homeostasis of zinc is altered during depression and its therapy.
27,28 During a successful antidepressant treatment, the levels of zinc are increased in the hippocampus 39 and, by itself, zinc exerts antidepressant-like effects. 30 Therefore, during treatment for depression, nAChRs are under the simultaneous influence of both zinc and fluoxetine. Furthermore, our results show that the behavior of nAChRs differs, depending on when these two substances reach the receptors. For example, if nAChRs are already interacting with zinc, fluoxetine exerts a stronger nAChR inhibition than in the absence of zinc. Additionally, in animal models of depression, ineffective doses of antidepressants become effective by co-administration with very low doses of zinc. 32, 40 Alternatively, if nAChRs are already interacting with fluoxetine and the concentration of zinc then increases, due to the antidepressant treatment itself, 30, 39 zinc fails to exert its potentiating action; presumably because of the marked inhibition of nAChRs by fluoxetine.
It is known that zinc increases the antidepressant effects of imipramine and citalopram on animal models of depression, 32, 40 and increases also the efficacy of antidepressant therapy in humans. 33 Our results show that zinc increases the inhibitory action of fluoxetine on ACh-activated neuronal a4b4 and muscle a1b1gd receptors. Moreover, in the presence of both ACh and fluoxetine, zinc fails to produce an increase of ACh currents generated by a4b4 receptors and only a small increase resulted in muscle a1b1gd receptors. These differences may be due to the drugs acting on molecular sites, already present on the various subunits that make up the receptors, and possibly also at new sites that may be uncovered by the action of the drugs applied previously. Whatever the mechanisms of these complex interactions turn out to be, it is clear that they may play an important role in the treatment of depression. Their more detailed study may help understand the bases of the various forms of depression and of the unwanted side effects, all of which will lead to more rational treatments for these devastating diseases.
MATERIALS AND METHODS
The preparation of RNA and oocyte injection have been described elsewhere. 10, 16 Briefly, cRNAs encoding the mouse muscle (a1, b1, g and d) and rat neuronal (a4 and b4) nAChR subunits were transcribed in vitro and mixtures, with equal quantities of RNA subunits, were prepared to express a1b1gd and a4b4 combinations. All experimental manipulations were made according to the ethical policies of animal care and handling of the National University. Xenopus laevis oocytes were manually dissected from segments of ovary, defolliculated with collagenase 41 and maintained at 161C in Barth's solution containing (in mM): 88 NaCl, 1 KCl, 0.33 Ca(NO 3 ) 2 , 0.41 CaCl 2 , 0.82 MgSO 4 , 2.4 NaHCO 3 , 5 HEPES (pH 7.4; NaOH), and 0.1 mg/ml gentamicin sulfate. The next day, each oocyte was injected with 0.5-50 ng of the cRNA mixture in a volume of 50 nl water. Membrane currents elicited by acetylcholine (ACh currents) were recorded 3-9 days after RNA injection using a voltage-clamp technique with two microelectrodes. 42 Oocytes were placed in a chamber (0.1 ml) and continuously perfused with Ringer's solution containing (in mM): 115 NaCl, 2 KCl, 1.8 CaCl 2 , 5 HEPES (pH 7.0; NaOH), at room temperature (20-231C) and at a rate of 7-10 ml/min. Chemicals (ACh, ZnCl 2 and fluoxetine) were from Sigma-RBI and were diluted in Ringer. The effect of each substance was estimated as the ratio between the current elicited by ACh plus the substance (zinc and fluoxetine alone or in combination) over the corresponding control current value at the end of application of the substances, giving the fraction of the ACh current that remains at this time. Unless otherwise indicated, the oocyte membrane potential was maintained at À60 mV and the results are given as the mean7standard error.
